Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

[Added benefits of systemic uro-oncological therapies-risk of recourse following elimination of the special practice designation : Part 1: prostate cancer].

Created on 17 Oct 2026

Authors

Manfred Johannsen, Roger Zillmann, Jörg Klier, Christian Doehn, Sulafah El-Khadra

Published in

Urologie (Heidelberg, Germany). Oct 16, 2026. Epub Oct 16, 2026.

PMID:
42886382
Bibliographic data and abstract were imported from PubMed on 17 Oct 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 13
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement